Jena, Germany, November 1, 2023 - InflaRx N.V. , a biotechnology company pioneering anti-inflammatory therapeutics targeting the complement system, announced today financial results.
InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Christians campaigning for greater transparency around decisions made in the care of critically ill children have expressed disappointment at the outcome of a review led by the Nuffield Council on Bioethics.